As shown in several studies [26–28], higher levels of preoperative serum tumor markers, such as CEA, CA125 and CA153 could represent tumor burden and have been suggested to be independent risk factors for the prognosis of breast cancer. The gene discussed is MUC16; the disease is neoplasm.